Correlation Between Kura Oncology and Adagene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and Adagene, you can compare the effects of market volatilities on Kura Oncology and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Adagene.

Diversification Opportunities for Kura Oncology and Adagene

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Kura and Adagene is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Kura Oncology i.e., Kura Oncology and Adagene go up and down completely randomly.

Pair Corralation between Kura Oncology and Adagene

Given the investment horizon of 90 days Kura Oncology is expected to generate 14.76 times less return on investment than Adagene. But when comparing it to its historical volatility, Kura Oncology is 1.53 times less risky than Adagene. It trades about 0.0 of its potential returns per unit of risk. Adagene is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  133.00  in Adagene on September 20, 2024 and sell it today you would earn a total of  71.00  from holding Adagene or generate 53.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kura Oncology  vs.  Adagene

 Performance 
       Timeline  
Kura Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Adagene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Adagene is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Kura Oncology and Adagene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kura Oncology and Adagene

The main advantage of trading using opposite Kura Oncology and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.
The idea behind Kura Oncology and Adagene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Correlations
Find global opportunities by holding instruments from different markets